Abstract. Synchronization programs have become standard components in the current breeding management of cows in the dairy herds of most dairy industries. Many are based on protocols that allow timed inseminations (TAI) so as to circumvent the practical difficulties associated with estrus detection. These difficulties are exacerbated in modern herds of high producing cows either because of increasing herd size in which individual animal monitoring is difficult and often subjective, or because small intensively managed herds are milked in robotic systems that minimize animal: staff interactions. Additional reasons arise from high producing cows having less obvious symptoms of estrus, partly because of housing systems combined with intensive feeding and milking, partly because of higher metabolic clearance rates of reproductive hormones like estradiol and partly because of the increasing prevalence of prolonged post-partum anestrus and reproductive tract pathology. The most recently developed programs include protocols for resynchronization following first or subsequent inseminations. These re-synchronization protocols may involve selected forms of hormonal intervention during the diestrous and pro-estrous periods following TAI, or following pregnancy diagnosis by ultrasound from 28 days after TAI. The latter form of re-synchronization has become increasingly important with the recognition that late embryonic/early foetal death has become a major factor compromising the reproductive performance of high producing Holstein cows in many dairy industries. Although cows detected in estrus without any hormonal treatment before insemination have higher conception rates than those inseminated following synchronization and TAI, the low detection rates combined with embryonic death means that intervals from calving to conception (days open) are usually less when synchronization programs have been successfully implemented. One of the significant factors affecting a program's success is the compliance rate that may sometimes be less than 70%. Almost all programs involve strategically timed injections of prostaglandin F2α (PGF) and gonadotropin releasing hormone (GnRH). Injections of an estradiol ester and progesterone supplementation per vaginum may be included in some programs. The basic program is the "Ovsynch" regimen. Numerous variations have been tested and developed. Many involve increasingly complex protocols that increase the risk of non-compliance, none has consistently achieved conception rates that exceed 40% and few have reduced the incidence of embryonic death. These synchronization programs are the best that are currently available. They have not been able to overcome the consequences of lowered fertility associated with high levels of milk yield, forms of nutrition and environmental factors like heat stress that have profound effects on the physiology and metabolism of the high producing dairy cow.
(J. Reprod. Dev. 56: S42-S47, 2010) he decline in the reproductive performance of Holstein cows of high genetic merit for milk yield has been widely recognised for the last decade and reported upon in many dairy industries. However, the specific reasons for the decline have not been documented apart from demonstrating associations with high early lactation milk yields, rapid mobilisation of body reserves as reflected by declining body condition score (BCS) and related health issues such as pathological conditions of the reproductive tract, lameness and mastitis. However, it seems likely that some of the hormonal changes that have been shown to influence energy partitioning resulting in increased lactose synthesis may also have indirectly altered some aspects of reproductive endocrinology. For example, reductions in plasma concentrations of insulin and IGF-I may have increased the availability of glucose to the udder or allowed high concentrations of somatotropin to be maintained, but have also compromised important roles for insulin and IGF-I in ovarian and uterine function. These associations may be directly related to or exacerbated by environmental and management conditions. For example, the susceptibility to heat stress is increased by having to feed high energy rations to cows in peak lactation consequently increasing rumen heat loss during periods when thermo-neutrality is difficult to maintain. Changes in the design of feeding barns and milking parlours have allowed increases in herd size to be accommodated without increasing labour units meaning there are more cows per labour unit. Specialized staff may be retained for conducting the milking process which is also readily able to be supervized as uniform standardized routines can be applied. The same management advantages are less relevant to reproductive management where each animal must be considered as an individual within its own estrous cycle so that estrus, ovulation, insemination, fertilisation and conception occur within a sequence that is within restricted behavioural and biological limits. Similar situations can arise with the management of parturition, but they are usually less complex and more predictable.
Correspondence: KL Macmillan (e-mail: k.macmillan@unimelb.edu.au) Estrus detection and animal identification have become increasingly difficult in large dairying operations to the extent that decisions related to the breeding management of individual cows are usually made by "barn" staff working with cows that may only have limited periods to interact in an unrestricted manner. This situation can limit the likely expression of the classic symptoms of behavioural estrus; namely, standing when mounted by a herdmate. Even the intensity of these symptoms may be reduced because of cow size, lower concentrations of estradiol that are more rapidly metabolised or unsuitable footing.
The interactions involving physiological, pathological, genetic and management/herd environment interactions have made it difficult to quantify the cause-and-effect relationships that have contributed to the recognised decline in dairy cow fertility. Estrus detection rates of over 90% have been reported with cows that have recommenced cycling in herds with seasonally concentrated calving systems that can express estrus under ideal conditions when grazing pasture. However, an increasing incidence of early lactation anovulatory anestrus combined with a greater likelihood of early embryonic death without a return to estrus has meant that even under these conditions, parameters such as the inter-estrus interval and non-return rate are no longer able to be used as indicators of reproductive performance at the cow or herd level [1] . Comparative levels of estrus detection in many high producing, large commercial herds that receive total mixed rations and are housed have declined to less than 50%. Under these circumstances, reproductive performance at cow or herd level can only be approximated by parameters such as days to first service, days open, calving interval, etc. These parameters may not be normally distributed and usually exclude cows that failed to conceive to the point of being removed (culled) from the herd. Hazard or survival analyses can be difficult to interpret when a range of factors may be influencing conception outcomes.
Under these circumstances, it is not surprising that synchronization programs have become increasingly common, especially those that allow every animal within a selected group of cows within a herd to receive a programmed series of preparatory injections or treatments culminating in either a short intensive period of inseminating associated with detected estrus, or insemination at a predetermined time without regard to estrus (timed AI; TAI). This review will summarise the development of TAI programs and identify some of the consequences of their increased use in herds of high producing dairy cows.
Evolution of Synchronization and Controlled Breeding Programs

Progestogens
Initial treatments focused on synchronizing behavioural estrus as a prelude to insemination. Potent synthetic progestogens were administered orally or by subcutaneous implants to heifers or beef cows but were unable to be used with lactating dairy cows because of hormonal residues in the milk likely to be orally active. The principle involved in these forms of treatment was to extend the normal estrous cycle by extending the period of diestrus. Induced luteolysis was attempted by injecting high doses of long acting estradiol esters.
Prostaglandin F2α
The identification of prostaglandin F2α (PGF) as the "uterine luteolysin" was quickly followed by the commercialisation of a natural synthetic form (Lutalyse) [2] and potent analogues (Estrumate) [3] . Their use was based on shortening the luteal phase by injecting PGF to induce luteolysis. This meant that a treatment was only effective in the presence of a functional corpus luteum from Day 7 to Day 17 of a normal estrous cycle (Estrus=Day 0). Although luteolysis could be successfully synchronized when a PGF was administered during this period, the interval to the onset of behavioural estrus could vary from 2 to 5 days. This variation was due to differences in the size of the dominant ovarian follicle at the time of injection and was demonstrated to be closely related to the wave-like pattern of normal follicle development. For example, when dairy cows were injected with PGF on Day 6 of their cycles, the average interval to estrus and insemination was 3.7 days, increasing to 4.9 days for injections at Day 10 and then declining to 3.4 days at Day 16 [4] . The percentage detected in estrus from 3 to 10 days after injection increased from 81 to 98% with advancing stage of diestrus at the time of PGF injection. These results clearly showed that synchronizing luteolysis did not result in the synchronized onset of estrus and ovulation. Detecting behavioural estrus had to be a necessary component of synchronizing estrus within a prostaglandin system. However, when cows were inseminated following the estrus associated with a single PGF injection, their pregnancy rates were significantly higher than in untreated contemporaries (70.5 vs. 58.5%; n=1151 & 1450) [5] .
Although the degree of synchronization of luteolysis was enhanced by the administration of a second injection of PGF from 9 to 14 days after the first, the response to the second injection in terms of cows detected in estrus was frequently less than predicted. For example, Xu et al. [6] reported that whereas 78.5% of cows were detected in estrus within 7 days of the first injection of PGF, it only increased to 82.5% after the second injection given 13 days later. The poorest response to the second injection of 77% was from cows that were at Days 5 to 9 of their cycles when given the second injection. In contrast to original reports using 2 × PGF protocols, the treated cows that were inseminated following a detected estrus had lower conception rates to first insemination than untreated contemporaries (61.1 vs. 70.5%) [6] . As with the estrus response, the greatest difference in conception rate involved those cows inseminated when injected at early stages of their cycles (Days 5 to 9=45.9%; Days 10 to 13=67.7%; Days 14 to19=67.5%).
These reduced responses involving cows at Days 5 to 9 of their cycles at the time of the second injection would be associated with an extended interval of low progesterone between the two injections. If progesterone was supplemented per vaginum for a period of 5 days before the second injection of PGF, the estrus response rate was increased from 82.9 to 89.6% and the conception rate from 59.7 to 65.1% so that the pregnancy rate over the first 6 days of inseminating was increased from 49 to 59.3% [6] . Most of the beneficial treatment responses involved the cows that were at Days 5 to 9 of their cycles.
It is likely that results obtained from routinely using 2 × PGF protocols with lactating cycling dairy cows could be enhanced by the strategic use of supplemental progesterone.
Gonadotropin Releasing Hormone
As with prostaglandin F2α, the identification of gonadotropin releasing hormone (GnRH) as the "LH releasing agent" was quickly followed by the natural form and potent analogues of GnRH being synthesized. They were initially used to treat cystic follicles (Cystorelin) and delayed ovulation in dairy cows. However, trials that were initiated to study its use to improve the precision of the synchronized estrus with 2 × PGF treatments showed that injecting a GnRH analogue (buserelin) from as little as 15 min and as much as 3 days before injecting PGF, extended the interval from the PGF injection to estrus from 4.6 days to 7.9 days as well as reducing the estrus response rate. The latter interval was the approximate duration of an ovarian follicle wave. The mechanisms for these effects was shown to be associated with the luteinization of ovarian follicles so that they could no longer produce estradiol with the consequential effect of preventing complete luteolysis by the injected PGF [7] [8] [9] . These effects were incorporated into the design of two field trials which showed that injecting 10 μg of the GnRH analogue buserelin from 8 to 10 days after insemination could significantly improve conception rates [10] ; subsequent studies could not confirm this benefit [11] .
Combinations of PGF and GnRH
Once it was shown that delaying the interval between an injection of PGF until 7 days after an initial injection of GnRH would not compromise the PGF-induced luteolysis, it became possible to produce a synchronized estrus. This was because the injected GnRH had synchronously terminated most stages of ovarian follicle development to be followed by a synchronized emergence of a new follicle wave leading to the presence of a maturing dominant follicle 7 days after injection [12, 13] . These initial studies utilised lactating beef cows that were cycling as well as anestrus and beef heifers. It was reported that the basic GnRH-PGF-GnRH protocol was equally effective with each classification of female.
Although the original studies using combinations of GnRH and PGF were conducted and reviewed by Thatcher et al. [9] , it was the comprehensive studies by Pursley et al. [14, 15] that demonstrated the suitability of the basic "Ovsynch" protocol. This involved a series of injections using a synthetic natural forms of both GnRH (Gonadorelin at 100 μg i.m.) and PGF ( Dinoprost at 25 mg i.m.), with a 7 day interval from the first GnRH injection to PGF followed 30 to 36 h later by the second GnRH and timed AI (TAI) 16 to 20 h later [14] . The pregnancy rates per AI were 38.9% in PGFtreated control cows inseminated following detected estrus compared to 37.8% in the Ovsynch treated cows. In contrast, the latter protocol was not successful in non-lactating Holstein heifers (74.4 vs. 35.1%) due to lack of synchronization. The use of the Ovsynch protocol with cows that had a standardised voluntary waiting period of 50 days increased herd pregnancy rates at 60 days postpartum from 5 to 37%, and at 100 days from 35 to 53% [15] . A subsequent study showed that the interval from the second GnRH injection to insemination could be varied from 0 to 32 h, although highest pregnancy rates (45%) were with an interval of 16 h [16] .
This study was also one of the first to report that the calving rate of 29% in the synchronized Holstein cows was 10% lower than the original pregnancy rate of 39% because 22% of embryos present at pregnancy diagnosis were lost [16] .
Recent Variations to the Ovsynch Program
The basic component of the Ovsynch program and its many variations that has remained unchanged has been the interval of 7 days between the first GnRH injection and the following PGF one. Those that have included estrus detection following the PGF injection and before the ovulating injection of GnRH have been referred to as "Heatsynch". Attempting to synchronize the patterns of follicle development before the first GnRH injection either with a GnRH or PGF injection,or two PGF injections have been referred to as "Presynch". Others have been described as "Selectsynch" and "Cosynch". A meta-analysis of 71 trials that had "treated and control groups" around the basic Ovsynch program that were reported in 53 manuscripts concluded that: "There was little or no significant improvement in pregnancy rates using Ovsynch over other programs" [17] .
It is likely that underlying differences between the cows enrolled in these comparative studies may have contributed to the variation in the results obtained in many of these trials. For example, results from 9 studies recently summarised by Bamber et al. [18] reported an average of 14.4% pregnancy loss among 3,775 cows between about 30 and 60 days post-TAI, varying from 7.6 to 21.6%. They also reported that the heritability of the condition (on a sire-son regression basis) was 0.49. The same study showed that the incidence of anestrus at about 56 days post-partum (based on plasma progesterone concentrations) ranged from 7.3 to 41.7% around an average of 23.3% and a calculated heritability of 0.19.
Anestrus is now recognised as being associated with a reduced ability by GnRH to terminate an ovarian follicle wave and/or to initiate the emergence of a new wave. Cordoba and Fricke [19] reported that 51% of the 49 cows that were treated with Ovsynch, but failed to conceive to the TAI were detected in estrus either within 13 days (22%) or from 14 to 17 days (29%) following TAI. Most of the cows with abnormal progesterone profiles had been or were anestrus. These anestrous cows with irregular return patterns to TAI were the main reason why the conception rate to TAI was only 27.3%, whereas it was 47.3% in cows not synchronized but accurately detected in estrus before being inseminated. Shepherd [20] made similar observations relating to a high incidence of return-to-service intervals of less than 18 days in a study in which 3559 cows in New Zealand and Australian herds were synchronized using Ovsynch combined with TAI. Clearly, conception rates will not be maximised if the sychronization protocol that has been used does not achieve precise control of ovarian follicle development [11] . Attempts to enhance the control of ovarian follicle development have included the addition of an extra GnRH injection or administering two PGF injections 14 days apart before initiating the Ovsynch protocol (Presynch). The latter alternative is now widely used in American herds preceding a first TAI at about 60 days post-partum. While the Presynch protocol can improve the results obtained with cows that have ovulated before the first PGF injection, it is less effective with anestrous cows [21] .
The general consequences of anestrus in lactating Holstein cows in American herds were highlighted by Chebel et al. [21] . They showed that cows that had ovulated a follicle to the first GnRH injection had a 31-day pregnancy rate of 37% compared to 21% in cows that failed to have an induced ovulation. However, pregnancy loss rates at Day 60 were higher in the ovulating group (25 vs. 15%). The presence or absence of a corpus luteum at the time of the PGF injection preceding the second GnRH injection had an even more dramatic effect on the 31-day pregnancy rate (+ CL= 40%; -CL=8%). The associated pregnancy loss rates were 20 and 28% respectively. The overall effect of these differences was that the 31-day and 60-day pregnancy rates for cyclic cows were 37 and 29% compared to 20.6 and 16.7% in anestrous contemporaries [21] .
Treating Anestrus in Lactating Dairy Cows
Extended periods of post-partum ovarian inactivity as reflected by failure of ovulation will extend the interval from calving to first insemination as well as days open with significant effects on intercalving interval and lifetime productivity. There is an obvious case for intervention, but the likely treatment outcomes rarely produce reproductive results as good as those obtained with cows that recommence cycling within 30 days of calving [21, 22] .
The most successful treatments for anestrus have usually involved a period of progesterone supplementation almost invariably using an intravaginal insert. Chebal et al. [21] showed that a 7-day treatment with an intravaginal progesterone insert (ivagP4 insert) increased the incidence of ovulation in anestrous cows by Day 62 of the study protocol from 30% to 46%. Rhodes et al. [22] reported that combining a 7-day or 8-day treatment with an invagP4 insert with injections of estradiol benzoate (1 or 2 mg im) coincidentally with treatment initiation and 24 after insert removal (1 mg im) could achieve estrus in over 90% and ovulation in over 80% of anestrous cows. More recent studies in New Zealand and Australia have demonstrated that GnRH can be substituted for estradiol benzoate but must also involve TAI. However, conception rates involving the treatment of anestrous Holstein cows in Australian herds have not been as successful as those with the smaller anestrous Friesian cows that make up New Zealand herds [20] . In spite of this difference, the treatment of anestrus has not produced conception rates to first inseminations following TAI or detected estrus in Holsteins or Friesians that are as high as those obtained with cycling contemporaries [19, [21] [22] [23] [24] .
This has lead to the development of post-insemination treatments with intrvagP4 inserts that have either been previously used for pre-insemination treatments or as separate treatments with a new insert. The recommended protocol with anestrous cows in New Zealand herds involves an initial 7 or 8 days of progesterone supplementation with an invagP4 insert. The shorter interval is used when GnRH is part of the protocol, whereas estradiol benzoate is used with the longer one. This initial treatment is followed by re-synchronization involving the previously used or new invagP4 insert being reapplied at about 14 days after insemination. Estradiol can be used as part of the retreatment protocol with insert removal 8 days later, but GnRH cannot be used in this way [25, 26] . Variations on this basic "double" treatment regimen have been tested with Holsteins in American herds with variable results. ElZarkouny and Stevenson [27] as well as Chebel et al. [21] both reported that the post-insemination use of an ivagP4 insert could reduce pregnancy loss through increased embryo survival rate from around Day 30 to Day 60 post-insemination. However, little cognisance has been given to the likely reasons for any effects, given the limited effect of the invagP4 inserts to significantly increase plasma concentrations of progesterone in large, high producing lactating Holstein cows.
Some Effects of Progesterone Supplementation
The original studies to measure changes in plasma progesterone concentrations in animals treated with the CIDR invagP4 insert used non-lactating 19-month old beef heifers that weighed approximately 400 kg [28] . The insert had been designed originally to be able to be used with Jersey heifers at 15 months of age and weighing only 300 kg live weight in New Zealand herds. In the case of the beef heifers that were treated during diestrus, plasma progesterone concentrations were increased by 66.7%, or 5.8 ng/ml by 24 h and remained elevated to be 48.2% or 4.5 ng/ml higher after 4 days. By contrast, the average elevation in 9 ovariectomised cows treated with a single invagP4 insert was 6.7 ng/ml at 24 h and then steadily declining to 2.3 ng/ml at 15 days [29] . Mann et al. [30] used nonlactating Holstein cows to show that the application of an invagP4 insert during early diestrus increased plasma progesterone concentrations by a similar average of 67.5% average or 2.7 ng/ml, whereas treatments initiated after mid-diestrus increased concentrations by 41.2% or 3.3 ng/ml. However, only the early diestrous treatment significantly increased the production of interferon-τ as well as accelerating embryo development.
This positive effect was considered to be the reason why a metaanalysis of studies where progesterone supplementation initiated during early diestrus concluded that this form of use of invagP4 inserts with lactating cows could reliably be expected to increase conception rates [31] . The largest studies had been conducted in New Zealand using lactating cows that weighed about 450 kg. The multiple herd studies involving over 3000 cows showed that if a CIDR invagP4 insert was applied from 4 to 9 days after first insemination for from 6 to 12 days, conception rates could be increased from 66.1% in untreated cows to 74.6% in the treated contemporaries [29] . Subsequent field trials have not been able to demonstrate a consistently positive effect because of significant herd × treatment interactions [11] .
The situation may be quite different in lactating Holstein cows receiving an invagP4 insert during peak lactation when daily yields may exceed 40 litres. For example, Sartori et al. [32] showed that Holsteins (likely weighing over 600 kg) that were receiving a total mixed ration to average 45 l/day with 3 × daily milking had peak diestrous concentrations of progesterone that were only 66% of those measured in non-lactating Holstein heifers (4 vs. 6 ng/ml). This occurred in spite of the cows having average luteal tissue volumes that were 50% greater at mid-cycle. These authors concluded that the lower concentrations of progesterone were associated with higher metabolic clearance rates.
In a subsequent study [33] , 62 lactating Holstein cows that had been injected with PGF during diestrus and then had a CIDR invagP4 insert applied 48 h later had a "plateau" concentration of progesterone of 0.9 ng/ml. Only 19% of samples recovered during the 7 days before insert removal exceeded 1 ng/ml and 22.6% of cows ovulated during this period. These figures concur with results obtained by Chenault et al. [34] . They showed that average concentrations of progesterone in defatted milk samples were only increased by 9.2% (3.03 vs. 3.33 ng day/ml) when lactating Holstein cows were treated with a CIDR invagP4 insert for 7 days. This increase was not statistically significant and meant that the milk from the treated cows had significantly lower concentrations than progesterone measured in the milk from pregnant contemporaries (3.33 vs 3.81 ng day/ml).
While positive treatment effects through using CIDR invagP4inserts as part of an Ovsynch-related protocol combined with their use for re-synchrony has improved pregnancy rates in some studies [21, 27] , the mechanism for these effects remain to be elucidated. If the increases in plasma concentrations of progesterone that were reported by Macmillan et al. [28] , Macmillan and Peterson [29] and Mann et al. [27] were able to be achieved in lactating Holstein cows, it is possible that more consistent and greater increases in pregnancy rates at 60 days after TAI could be achieved. This hypothesis could be tested by applying either two or three CIDR invagP4 inserts. For example, whereas a single insert produced an average increase in progesterone concentrations of 2.8 ng/ml with cows in a New Zealand study, simultaneously applying three inserts increased the average concentration by 8.4 ng/ml [29] .
Conclusions
Sychronization programs have been successful in reducing the intervals from calving to conception in many management systems, but especially those where detecting estrus is problematical and where high producing cows may display less obvious behavioural symptoms. However, the increasing use of Ovsynch programs and its numerous variations has coincidentally been associated with an increasing incidence of anestrus and early embryonic death. Both conditions require more frequent intervention either before TAI in the case of anestrus, or after TAI as well as re-synchronization in the case of early embryonic death. Both of these factors have also contributed to lower pregnancy rates as well as an increasing a reliance on TAI protocols as a means of reducing their impact on herd reproductive performance.
A longer term solution will require genetic intervention. Although anestrus was estimated to be only moderately inherited (0.17 to 0.19), early embryonic death was estimated to be highly inherited (0.49) using a sire-maternal grand sire model [18] . Of particular note was the observation that: "the embryo's ability to survive has a greater effect on pregnancy loss than the cow's ability to maintain the pregnancy" [18] .
Although progesterone supplementation has been demonstrated to have some advantages in some studies, its rapid metabolism in high producing Holstein cows may mean that novel variations in combination with variations to Ovsynch protocols deserve to be evaluated.
